Variant report
Variant | esv1817834 |
---|---|
Chromosome Location | chr1:224052449-224095114 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:224052000-224052600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr1:224052400-224052800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr1:224052600-224057800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr1:224052800-224058200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr1:224057600-224058200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr1:224057800-224058600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
7 | chr1:224057800-224059400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr1:224057800-224059400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr1:224057800-224060600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr1:224057800-224062000 | Enhancers | K562 | blood |
11 | chr1:224058000-224058600 | Enhancers | Primary monocytes fromperipheralblood | blood |
12 | chr1:224058000-224059400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr1:224058000-224059400 | Enhancers | Placenta | Placenta |
14 | chr1:224058200-224058400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr1:224058200-224058600 | Enhancers | H9 Cell Line | embryonic stem cell |
16 | chr1:224058200-224058600 | Bivalent Enhancer | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr1:224058200-224058600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr1:224058200-224058600 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
19 | chr1:224058200-224058600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
20 | chr1:224058200-224058800 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
21 | chr1:224058200-224059200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
22 | chr1:224058200-224059200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
23 | chr1:224058200-224059200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
24 | chr1:224058400-224058600 | Enhancers | Pancreas | Pancrea |
25 | chr1:224058400-224058800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
26 | chr1:224058400-224058800 | Enhancers | Dnd41 | blood |
27 | chr1:224058400-224059000 | Enhancers | H1 Cell Line | embryonic stem cell |
28 | chr1:224058400-224059000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
29 | chr1:224058400-224059000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
30 | chr1:224058400-224059200 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
31 | chr1:224058400-224059200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
32 | chr1:224058400-224059200 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
33 | chr1:224058400-224059400 | Bivalent/Poised TSS | HepG2 | liver |
34 | chr1:224058600-224058800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
35 | chr1:224058600-224058800 | Enhancers | Placenta Amnion | Placenta Amnion |
36 | chr1:224058600-224059000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
37 | chr1:224058600-224059000 | Flanking Active TSS | Primary monocytes fromperipheralblood | blood |
38 | chr1:224058600-224059000 | Enhancers | Primary B cells from cord blood | blood |
39 | chr1:224058600-224059000 | Active TSS | Pancreas | Pancrea |
40 | chr1:224058600-224059200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
41 | chr1:224058600-224059400 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
42 | chr1:224058800-224059200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
43 | chr1:224058800-224059200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
44 | chr1:224058800-224059200 | Active TSS | Dnd41 | blood |
45 | chr1:224059000-224059200 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
46 | chr1:224059000-224059200 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
47 | chr1:224059000-224059200 | Enhancers | Pancreas | Pancrea |
48 | chr1:224059000-224059400 | Enhancers | Primary monocytes fromperipheralblood | blood |
49 | chr1:224059000-224060000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
50 | chr1:224059000-224060200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |